BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38104042)

  • 1. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
    Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
    Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
    Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
    Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.
    May CD; Sphyris N; Evans KW; Werden SJ; Guo W; Mani SA
    Breast Cancer Res; 2011 Feb; 13(1):202. PubMed ID: 21392411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
    Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
    Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
    Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Pizarro D; Caniego-Casas T; Cortés J; Palacios J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
    Micalizzi DS; Farabaugh SM; Ford HL
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis.
    Ahmed SS; Lim JCT; Thike AA; Iqbal J; Tan PH
    J Clin Pathol; 2022 May; 75(5):316-323. PubMed ID: 33627375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression.
    Jørgensen CLT; Forsare C; Bendahl PO; Falck AK; Fernö M; Lövgren K; Aaltonen K; Rydén L
    Breast Cancer Res Treat; 2020 Jun; 181(2):369-381. PubMed ID: 32300922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
    Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
    PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
    Loo SY; Hirpara JL; Pandey V; Tan TZ; Yap CT; Lobie PE; Thiery JP; Goh BC; Pervaiz S; Clément MV; Kumar AP
    Antioxid Redox Signal; 2016 Aug; 25(6):283-99. PubMed ID: 27400860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Breast Tumors with Mesenchymal Morphology.
    Tevatia MS; Mishra P; Baranwal AK; Nichat PB; Shelly D; Awasthi S; Sengupta P
    J Lab Physicians; 2021 Dec; 13(4):362-367. PubMed ID: 34975257
    [No Abstract]   [Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
    Mallini P; Lennard T; Kirby J; Meeson A
    Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
    Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
    BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma).
    Nistor-Ciurba CC; Şomcutian O; Lisencu IC; Ignat FL; Lazăr GL; Eniu DT
    Rom J Morphol Embryol; 2020; 61(1):129-135. PubMed ID: 32747903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition.
    Zhang Y; Toy KA; Kleer CG
    Mod Pathol; 2012 Feb; 25(2):178-84. PubMed ID: 22080057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.